These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 17350879

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A, Kumar VS, Shamim SA, Gamanagatti S, Khan SA.
    Clin Orthop Relat Res; 2021 Aug 01; 479(8):1768-1779. PubMed ID: 33635285
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.
    Fujimoto R, Higashi T, Nakamoto Y, Hara T, Lyshchik A, Ishizu K, Kawashima H, Kawase S, Fujita T, Saga T, Togashi K.
    Ann Nucl Med; 2006 Jul 01; 20(6):399-408. PubMed ID: 16922468
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun 01; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
    Teke F, Teke M, Inal A, Kaplan MA, Kucukoner M, Aksu R, Urakci Z, Tasdemir B, Isikdogan A.
    Asian Pac J Cancer Prev; 2015 Jun 01; 16(1):387-91. PubMed ID: 25640386
    [Abstract] [Full Text] [Related]

  • 12. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M, Kupik O, Karabulut E, Høilund-Carlsen PF.
    Rev Esp Med Nucl Imagen Mol; 2016 Jun 01; 35(1):3-11. PubMed ID: 26514321
    [Abstract] [Full Text] [Related]

  • 13. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
    Ozülker T, Küçüköz Uzun A, Ozülker F, Ozpaçac T.
    Nucl Med Commun; 2010 Jun 01; 31(6):597-603. PubMed ID: 20224457
    [Abstract] [Full Text] [Related]

  • 14. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
    Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.
    Anticancer Res; 2005 Jun 01; 25(6C):4439-44. PubMed ID: 16334123
    [Abstract] [Full Text] [Related]

  • 15. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I, Sivrikoz MC, Entok E, Vardareli E.
    Eur J Cardiothorac Surg; 2010 Apr 01; 37(4):792-6. PubMed ID: 20015657
    [Abstract] [Full Text] [Related]

  • 16. (18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
    Choi YJ, Hwang HS, Kim HJ, Jeong YH, Cho A, Lee JH, Yun M, Lee JD, Kang WJ.
    Ann Nucl Med; 2014 May 01; 28(4):304-13. PubMed ID: 24481823
    [Abstract] [Full Text] [Related]

  • 17. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Pietrzak AK, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Urol J; 2018 Sep 26; 15(5):242-247. PubMed ID: 29681049
    [Abstract] [Full Text] [Related]

  • 18. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP.
    Neoplasma; 2002 Sep 26; 49(4):267-71. PubMed ID: 12382027
    [Abstract] [Full Text] [Related]

  • 19. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 Sep 26; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 20. The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer.
    Min JW, Um SW, Yim JJ, Yoo CG, Han SK, Shim YS, Kim YW.
    J Korean Med Sci; 2009 Apr 26; 24(2):275-80. PubMed ID: 19399270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.